You Are Here: Home > About Arthritis > Arthritis in the News > Innovative Medicines Canada bans members from paying doctors fees for IV infusions

Innovative Medicines Canada bans members from paying doctors fees for IV infusions

Pharmaceutical companies will no longer be allowed to pay fees to Canadian doctors for overseeing intravenous infusions of their medications under a revised ethical code written by the industry group for brand-name drug makers. The goal is to remove incentives that encourage doctors to prescribe drugs by IV when other forms might be more appropriate.Back to News